| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |